Insmed
INSM
#856
Rank
โ‚ฌ24.53 B
Marketcap
113,67ย โ‚ฌ
Share price
-2.25%
Change (1 day)
78.02%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚ฌ24.53 Billion

As of May 2026 Insmed has a market cap of โ‚ฌ24.53 Billion. This makes Insmed the world's 856th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ24.53 B-24.02%
2025โ‚ฌ32.29 B169.85%
2024โ‚ฌ11.96 B198.4%
2023โ‚ฌ4.01 B58.93%
2022โ‚ฌ2.52 B-11.37%
2021โ‚ฌ2.84 B3.27%
2020โ‚ฌ2.75 B44.22%
2019โ‚ฌ1.91 B115.63%
2018โ‚ฌ0.88 B-55.45%
2017โ‚ฌ1.99 B155.73%
2016โ‚ฌ0.77 B-24.15%
2015โ‚ฌ1.02 B61.96%
2014โ‚ฌ0.63 B31.5%
2013โ‚ฌ0.48 B202.52%
2012โ‚ฌ0.15 B173.05%
2011โ‚ฌ58.32 M-21.44%
2010โ‚ฌ74.23 M6.08%
2009โ‚ฌ69.97 M71.09%
2008โ‚ฌ40.9 M-40.62%
2007โ‚ฌ68.87 M1.93%
2006โ‚ฌ67.57 M-38.92%
2005โ‚ฌ0.11 B52.02%
2004โ‚ฌ72.77 M-19.65%
2003โ‚ฌ90.57 M535.42%
2002โ‚ฌ14.25 M-89.99%
2001โ‚ฌ0.14 B17.94%
2000โ‚ฌ0.12 B

End of Day market cap according to different sources

On May 2nd, 2026 the market cap of Insmed was reported to be:

โ‚ฌ24.53 Billion
by Nasdaq info icon info icon
โ‚ฌ24.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚ฌ238.55 B 872.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ139.38 B 468.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ91.97 B 274.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.93 B-92.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.64 B-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.02 B-95.83%๐Ÿ‡บ๐Ÿ‡ธ USA